{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:45:40Z","timestamp":1790873140751,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.bbrc.2009.06.077","type":"journal-article","created":{"date-parts":[[2009,6,19]],"date-time":"2009-06-19T08:22:55Z","timestamp":1245399775000},"page":"526-531","source":"Crossref","is-referenced-by-count":30,"title":["Cyclodextrins promote protein aggregation posing risks for therapeutic applications"],"prefix":"10.1016","volume":"386","author":[{"given":"Min S.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta","family":"Boddapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Sierks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2009.06.077_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0196-9781(01)00592-7","article-title":"Investigation of substance P transport across the blood\u2013brain barrier","volume":"23","author":"Freed","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.bbrc.2009.06.077_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","article-title":"Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease","volume":"70","author":"Camargo","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2009.06.077_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/0023210-200923010-00003","article-title":"Getting into the brain approaches to enhance brain drug delivery","volume":"23","author":"Patel","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbrc.2009.06.077_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0169-409X(98)00054-4","article-title":"Cyclodextrins in nasal drug delivery","volume":"36","author":"Merkus","year":"1999","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.bbrc.2009.06.077_bib5","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.bmcl.2006.01.049","article-title":"Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood\u2013brain barrier","volume":"16","author":"Tilloy","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbrc.2009.06.077_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1124\/jpet.104.071845","article-title":"Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood\u2013brain barrier","volume":"311","author":"Monnaert","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2009.06.077_bib7","doi-asserted-by":"crossref","first-page":"E329","DOI":"10.1208\/pt060243","article-title":"Cyclodextrins in drug delivery: an updated review","volume":"6","author":"Challa","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bbrc.2009.06.077_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1124\/jpet.104.067512","article-title":"Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood\u2013brain barrier","volume":"310","author":"Monnaert","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2009.06.077_bib9","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1074\/jbc.M205406200","article-title":"Trafficking of cholesterol from cell bodies to distal axons in Niemann pick C1-deficient neurons","volume":"278","author":"Karten","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.06.077_bib10","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.clinthera.2007.08.006","article-title":"Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies","volume":"29","author":"Pastores","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbrc.2009.06.077_bib11","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1(\u2212\/\u2212) mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2009.06.077_bib12","unstructured":"A.D. Marcus, The Wall Street J. (2009) A13."},{"key":"10.1016\/j.bbrc.2009.06.077_bib13","doi-asserted-by":"crossref","first-page":"A17","DOI":"10.1016\/S0016-5085(08)60091-8","article-title":"Treatment of the liver disease associated with Niemann Pick type C disease with ezetemibe anti 2-hydroxypropyl beta cyclodextrin results in near normalization of ALT and AST","volume":"134","author":"Liu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2009.06.077_bib14","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.ymgme.2007.08.026","article-title":"Miglustat in Niemann-Pick type C (NPC) disease: results of 12-months-treatment","volume":"92","author":"Patterson","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbrc.2009.06.077_bib15","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1471-4159.2006.04017.x","article-title":"Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy","volume":"98","author":"Bar-On","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2009.06.077_bib16","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2009.06.077_bib17","first-page":"985","article-title":"Dementia: a brief review","volume":"73","author":"Grossman","year":"2006","journal-title":"Mt. Sinai J. Med."},{"key":"10.1016\/j.bbrc.2009.06.077_bib18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/354432a0","article-title":"Alzheimers-disease \u2013 in the beginning","volume":"354","author":"Selkoe","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2009.06.077_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2009.06.077_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00309338","article-title":"Neurofibrillary tangles in Niemann-Pick disease type-C","volume":"89","author":"Suzuki","year":"1995","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbrc.2009.06.077_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1789.2006.00743.x","article-title":"Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies","volume":"26","author":"Yoshida","year":"2006","journal-title":"Neuropathology"},{"key":"10.1016\/j.bbrc.2009.06.077_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00401-002-0644-3","article-title":"Dementia with Lewy bodies from the perspective of tauopathy","volume":"105","author":"Iseki","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbrc.2009.06.077_bib23","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S1074-5521(00)00068-5","article-title":"Neurodegeneration: new clues on inclusions","volume":"7","author":"Lansbury","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbrc.2009.06.077_bib24","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","article-title":"Amyloid beta-protein fibrillogenesis \u2013 structure and biological activity of protofibrillar intermediates","volume":"274","author":"Walsh","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.06.077_bib25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","article-title":"Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives","volume":"77","author":"Mattson","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2009.06.077_bib26","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.1021\/bi9904149","article-title":"Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer\u2019s disease","volume":"38","author":"Harper","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2009.06.077_bib27","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","article-title":"Amyloid beta-protein fibrillogenesis \u2013 detection of a protofibrillar intermediate","volume":"272","author":"Walsh","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.06.077_bib28","doi-asserted-by":"crossref","first-page":"10786","DOI":"10.1523\/JNEUROSCI.2441-08.2008","article-title":"A beta oligomers induce neuronal cell cycle events in Alzheimer\u2019s disease","volume":"28","author":"Varvel","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2009.06.077_bib29","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1021\/bi700411k","article-title":"Methylene blue inhibits amyloid A beta oligomerization by promoting fibrillization","volume":"46","author":"Necula","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2009.06.077_bib30","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1074\/jbc.M608207200","article-title":"Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct","volume":"282","author":"Necula","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.06.077_bib31","doi-asserted-by":"crossref","first-page":"11532","DOI":"10.1021\/bi060601o","article-title":"Single chain Fv antibodies against the 25\u201335 A beta fragment inhibit aggregation and toxicity of A beta 42","volume":"45","author":"Zameer","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2009.06.077_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","article-title":"A quick and simple method for the quantitation of lactate-dehydrogenase release in measurements of cellular cyto-toxicity and tumor necrosis factor (Tnf) activity","volume":"115","author":"Decker","year":"1988","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbrc.2009.06.077_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple nonradioactive assay to monitor and determine the proliferation of lymphocytes \u2013 an alternative to [H-3] thymidine incorporation assay","volume":"170","author":"Ahmed","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbrc.2009.06.077_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-1759(94)90361-1","article-title":"A sensitive new bioassay for tumor-necrosis-factor","volume":"175","author":"Shahan","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbrc.2009.06.077_bib35","first-page":"5749","article-title":"Modeling of the time-dependency of in vitro drug cytotoxicity and resistance","volume":"58","author":"Levasseur","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2009.06.077_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bpc.2004.06.012","article-title":"Kosmotropes and chaotropes: modelling preferential exclusion, binding and aggregate stability","volume":"112","author":"Moelbert","year":"2004","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bbrc.2009.06.077_bib37","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1523\/JNEUROSCI.3829-06.2006","article-title":"Disease-modifying pathways in neurodegeneration","volume":"26","author":"Finkbeiner","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2009.06.077_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005727","article-title":"Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity","author":"Kvam","year":"2009","journal-title":"PLoS ONE"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09012200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09012200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T21:22:20Z","timestamp":1589923340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X09012200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0006291X09012200"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2009.06.077","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}